Rare diseases
Investigational molecules
Locations
290 conditions with trials, the busiest first
1 641 trials across Europe, recruiting first
Study on the Effects of Briquilimab in Adults with Chronic Spontaneous Urticaria Unresponsive to Antihistamines
GermanyStudy on Long-Term Safety and Effectiveness of Upadacitinib for Patients with Ulcerative Colitis
AustriaStudy on Briquilimab for Adults with Chronic Inducible Urticaria Unresponsive to H1-Antihistamines
GermanyStudy on MK-6194 for Treating Adults with Non-Segmental Vitiligo
BelgiumStudy on the Effects of EP262 for Adults with Chronic Spontaneous Urticaria
GermanyStudy on Leniolisib for Patients with Activated Phosphoinositide 3-Kinase Delta Syndrome and Impaired Liver Function
GermanyStudy on Mirikizumab for Children and Teens with Moderate to Severe Ulcerative Colitis
BelgiumStudy on Filgotinib for Children and Teens with Juvenile Idiopathic Arthritis
FranceStudy on Guselkumab and Etanercept for Treating Chronic Plaque Psoriasis in Children Aged 6 to 17 Years
BelgiumStudy Comparing Dolutegravir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide for HIV Treatment in Adults New to Antiretroviral Therapy
BelgiumStudy on Frexalimab for Treating Active Systemic Lupus Erythematosus in Patients
GreeceStudy on Optimizing Ciclosporin Treatment for Moderate to Severe Atopic Dermatitis in Adults, Adolescents, and Children
SpainThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
